Introduction
Stem cell transplantation has been used for the treatment of various diseases, [1] [2] [3] [4] [5] owing to their advantageous properties, including multidifferentiation potential, self-renewal ability, the capacity to localize to the lesion area, and the capacity to act as a functional substitute for damaged cells. 6 However, the characteristics of engrafted stem cells, including cellular viability, biodistribution, differentiation capacity, and long-term fate, have not yet been determined. 6 Therefore, sequential visualization of engrafted stem cells in vivo is necessary to explore these mechanisms. 7 Currently, magnetic resonance imaging (MRI) is commonly used for noninvasive cell tracking in vivo. Recently, various types of nanoparticles have been utilized for cell labeling and cellular MRI to study stem cell transplantation, including Gd-loaded nanoparticles, 8, 9 iron oxide nanoparticles, 10 silica nanoparticles, 11, 12 quantum dots, 13 and upconversion nanoparticles. 14, 15 However, most of these particles are not ideal correspondence: rui-Ping Zhang Imaging Department, Affiliated Tumor hospital of shanxi Medical University, Number 3, Zhigongxin road, Taiyuan, shanxi, 030001, china email zrp_7142@163.com MR cell tracers, owing to inefficient cellular labeling, biotoxicity, or low relaxivity. For example, Gd(III)-based agents may produce nephrotoxicity, 16 and the dark signals produced by superparamagnetic iron oxide-based nanoparticles in T2-weighted images are difficult to distinguish from other tissues (such as the liver and spleen), physiological conditions (such as flow-void effects and air chambers), and diseases (such as hemorrhage and melanoma). 17, 18 Thus, many attempts to overcome such disadvantages have been made by searching for appropriate synthetic materials for nanoparticles to apply to cellular MRI.
Manganese is an essential element in humans, and is mainly distributed in the muscles, liver, kidneys, and brain in the form of manganese(II) ions. Manganese(II) can pass through calcium ion voltage-gated channels into the cell. 19 Hence, manganese(II) possesses much better biocompatibility than other paramagnetic metal ions, 20 particularly Gd(III) ions, which are widely applied as a clinical MR contrast agent.
Melanin is a ubiquitous pigment and an important chromophore in the human body. Melanin is produced by melanocytes, and is present in many human organs and tissues, including the skin, mucous membranes, retina, cerebral pia mater, and ovary. 21, 22 Melanin has many favorable properties, eg, good biocompatibility and metal ion chelation. Therefore, in recent years, increasing studies have explored the use of melanin in biological applications. [22] [23] [24] Melanin 24 Manganese(II) ions chelated to melanin nanoparticles [MNP-Mn(II)] are a novel type of nanoparticles used for stem cell MR tracking. These nanoparticles exhibit an ultrasmall size, minimal cytotoxicity, high relaxivity, and efficient and long-term cell labeling capacity. In this study, we report the development and characterization of these nanoparticles for stem cell labeling and cellular MR imaging of engrafted stem cells. All components of these nanoparticles were endogenous substances derived from humans. Our findings provide important insights into the potential applications of MNP-Mn(II) as novel cell MRI tracers in vivo.
Methods

synthesis and characterization of MNP-Mn(II)
Details of the synthesis and characterization of MNP-Mn(II) complexes are provided in the Supplementary materials.
MrI of MNP-Mn(II) aqueous solution
Samples of MNP-Mn(II) and Omniscan (an MRI contrast agent commonly used in the clinic) aqueous solutions were imaged using a clinical 3.0T instrument (Trivo; Siemens, Munich, Germany) with a wrist surface coil (diameter: 11 cm). The samples of MNP-Mn(II) and Omniscan aqueous solutions were placed in polymerase chain reaction (PCR) plates at different Mn(II) and Gd(III) concentrations (0.1, 0.2, 0.4, 0.8, and 1.0 mM), and pure water was used as a negative control. The concentrations of Mn(II) and Gd(III) in aqueous solution were measured by inductively coupled plasmaatomic emission spectrometry. T1-weighted imaging (T1WI) was performed twice using different repetition times (300 and 100 ms) to measure the T1 value. Other T1WI parameters were as follows: spin-echo sequence, field of view (FOV 
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Bone marrow-derived stem cell (BMsc) labeling BMSCs were harvested by primary culture, as described in our previous study. 26 Briefly, BMSCs were incubated in 25-cm 2 tissue culture flasks and, after reaching 70%-80% confluence, the medium was replaced with fresh complete culture medium containing MNP-Mn(II) at a concentration of 800 µg/mL. The cells were subsequently cultured for 24 h at 37°C in a 5% CO 2 incubator. The medium was then discarded, and the cells were carefully rinsed five times with phosphate-buffered saline (PBS) to remove the unlabeled MNP-Mn(II), followed by trypsinization. The pooled cells were obtained by centrifugation (1,000×g, 5 min) and then resuspended in 1 mL serum-free culture medium for future analysis.
Confocal fluorescence microscopy analysis
stirrer. The chelator MNP-Mn(II)-rhodamine-B was obtained though intermolecular crosslinking and electric attraction. The obtained MNP-Mn(II)-rhodamine-B aqueous solution was washed several times with ultrapure water in an ultrafiltration centrifuge tube (Amicon Ultra, 30 kDa; Millipore, Billerica, MA, USA) by centrifugation (4,000-5,000×g, 15 min) to remove unchelated rhodamine-B.
BMSCs were incubated with MNP-Mn(II)-rhodamine-B (200 µg/mL) for 4 h at 37°C. The cells were then washed with PBS three times and fixed with 4% paraformaldehyde for 15 min at 4°C. After drying, the cell nuclei were stained with 4′,6-diamidino-2-phenylindole (DAPI). Finally, the fluorescence images were recorded and analyzed by confocal laser-scanning microscope (FV1000; Olympus, Tokyo, Japan).
Transmission electron microscopy (TeM)
TEM was used to visualize the intracellular distribution of MNP-Mn(II). For this, MNP-Mn(II)-labeled and unlabeled cells were resuspended and centrifuged at 1,500×g for 5 min, yielding cell pellets. After the supernatants were removed, cell pellets were fixed at 4°C with 2% glutaraldehyde for 1 h, and washed with PBS several times. The cells were then post-fixed with 1% OsO 4 for 1 h, dehydrated in a graded series of ethanol solutions. The cells in ultrathin sections were obtained using an ultramicrotome (Leica EM UC-6; Leica Microsystems, Mannheim, Germany) and stained with uranyl acetate and lead citrate. Finally, the sections were visualized using a TEM (JEM-1011; JEOL).
In vitro cytotoxicity assessment
To assess the cytotoxicity of MNP-Mn(II), Cell Counting Kit-8 (CCK-8) assays were performed. Briefly, BMSCs were trypsinized and seeded on 96-well plates (5×10 3 cells/well). Cells were cultured overnight, and the medium was replaced with fresh Dulbecco's Modified Eagle's Medium/F12 containing MNP-Mn(II) or MNPs at various concentrations (0, 25, 50, 100, 200, 400, 800, and 1,600 µg/mL), followed by incubation for 48 h at 37°C in a 5% CO 2 incubator. Culture medium containing MNP-Mn(II) was then discarded, and the cells were subsequently washed three times with PBS. Fresh culture medium containing 10 µL CCK-8 reagent was added into the wells and incubated for 4 h at 37°C in a 5% CO 2 incubator.
Finally, the absorbance of each well was measured at 450 nm and recorded using a microplate reader (Infinite M1000; TECAN, Morrisville, NC, USA). All samples were assayed in triplicate.
In vitro MrI
After incubation with various concentrations of MNP-Mn(II) (0, 50, 100, 200, 400, and 800 µg/mL) for 24 h, cells were centrifuged and fixed with 4% paraformaldehyde for 20 min at 4°C. The cells were then resuspended and transferred to 96-well PCR plates at a density of 1.5×10 6 cells/well. T1-weighted imaging of the cells was performed using a clinical 3.0T MRI instrument (Trivo; Siemens) with a wrist surface coil (diameter: 11 cm). The detailed parameters were as follows: spin-echo sequence; FOV: 60×90 mm; matrix size: 180×256; slice thickness: 1.5 mm; spacing: 0.5 mm; TR: 500 ms; and TE: 20 ms.
In vivo MrI of engrafted BMscs
A total of four male Sprague-Dawley rats (Animal Center of Shanxi Medical University, Taiyuan, China; SYXK2015-0001; 6 weeks of age, weighing 70-80 g each) were used in this study.
All rats were intraperitoneally administered 1% pentobarbital sodium (40 mg/kg) for anesthetization. Intramuscular injection of a 100-µL suspension containing 2×10 6 BMSCs labeled with or without MNP-Mn(II) was then performed into the right hip. The injection positions were marked on the skin. MRI of the rats was carried out using a clinical 3.0T MRI instrument (Trivo; Siemens) with a wrist surface coil (diameter: 11 cm) on day 1 before injection and on days 1, 7, 10, 14, 21, and 28 after BMSC injection. The imaging parameters were the same as those of the above-mentioned in vitro MRI experiments.
The signal intensities (SIs) of the MNP-Mn(II)-labeled BMSC injection region and the adjacent soft tissue were measured, and the relative SIs were calculated to further evaluate the imaging capability of MNP-Mn(II)-labeled BMSCs in vivo. The area of the hyperintense signal generated by MNP-Mn(II)-labeled BMSCs was also measured at the same time.
Results and discussion
As shown in Figure S1 , MNP-Mn(II) nanoparticles exhibited many excellent properties, such as good water solubility, high stability, and ultrasmall and uniform particle size. Nonetheless, an MR-positive cell tracer must have high longitudinal relaxivity. To evaluate the T1-weighted imaging capability of MNP-Mn(II), we investigated the T1-weighted image SIs of MNP-Mn(II) and Omniscan aqueous solutions with various concentrations. As shown in Figure 1A Figure 1B , T1 relaxivity was significantly higher for MNP-Mn(II) (r1 = 19.916/mmol/s) than for Omniscan (r1 = 5.4962/mmol/s) under the same testing conditions. These results further suggested that MNPMn(II) had the potential to be applied to MR cell tracking in vivo.
Excellent cell tracers must also show effective cellular labeling and low cytotoxicity. 27 Therefore, the cell labeling capability of MNP-Mn(II) was investigated using rhodamine staining and TEM, and cytotoxicity was evaluated with CCK-8 assays. Laser scanning microscope images ( Figure 2) showed that many red fluorescent particles representing MNP-Mn(II)-rhodamine were present in the cytoplasm. TEM images ( Figure 3A and B) also showed that many black particles representing MNP-Mn(II) aggregated in the cytoplasm and lysosome of BMSCs, and there were no black particles in the cytoplasm or endosomes of unlabeled BMSCs. Fontana-Masson staining was further performed to evaluate the labeling rate of cells ( Figure S2 ). From these images, we found that almost all of the stem cells were successfully labeled with MNP-Mn(II) by 
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Promising Mr stem cell tracer using natural biomaterials co-incubation alone, without the need to use any transfection agents, demonstrating the excellent affinity of MNP-Mn(II) to the cells. As shown in Figure 4 , BMSCs labeled with 1,600 µg/mL MNP-Mn(II) exhibited very high cell viability. These results demonstrated that MNP-Mn(II) could be easily taken up and internalized by BMSCs without the aid of transfection agents, and that these nanoparticles had almost no cytotoxicity.
Based on these properties of MNP-Mn(II), we further assessed the in vitro and in vivo MRI of BMSCs labeled with MNP-Mn(II). As shown in Figure 5 , the cells were labeled with 0, 100, 200, 400, or 800 µg/mL MNP-Mn(II), and we found that cells labeled with 400 µg/mL exhibited the highest T1 SI at all labeling concentrations. However, the T1 SI at 800 µg/mL was lower than that at 400 µg/mL, potentially because the high concentration of MNP-Mn(II) in the cell may have shortened the transverse relaxation time. Thus, the peak of the signal could not be detected using the MR equipment, and the SI of the T1 images decreased. 28 This phenomenon was also observed for other paramagnetic contrast agents. 29 To further assess the capability of BMSCs labeled with MNP-Mn(II) for in vivo MRI, labeled BMSCs were intramuscularly injected into the right hips of rats. As shown in Figure 6A , a hyperintense T1 signal generated by MNPMn(II)-labeled BMSCs was observed in the right thigh after injection, and was maintained for at least 28 days; no hyperintense T1 signal was observed in the right thigh before injection. As shown in Figure 6 , on day 1 after injection, the relative SI of the hyperintense T1 signal region was the highest at all time points, and the relative SI decreased gradually over time. On day 28 after injection, the SI was maintained at a relatively stable level, sufficient to allow for monitoring of engrafted cells. In addition, the area of the hyperintense T1 signal increased gradually within 4 days after injection. After reaching a maximum on day 4 after injection, the area decreased gradually over time. These results supported the suitability of MNP-Mn(II) as novel cell MR tracers for use in the long-term monitoring of the fate of engrafted BMSCs in vivo.
Compared with other positive MR cell tracers, such as gadolinium-based MR contrast agents, the main advantage of the novel MNP-Mn(II) is their high level of biosafety; the main components (melanin and manganese) are endogenous substances found in the human body. Hence, MNP-Mn(II) have almost no cytotoxicity in labeled BMSCs, even when used at a very high concentration. Additionally, MNP-Mn(II) can be easily taken up and internalized by BMSCs only by co-incubation without any transfection agents. In addition, BMSCs labeled with MNP-Mn(II) can generate a brighter signal in T1-weighted images both in vitro and in vivo, owing to the higher T1 relaxivity of MNP-Mn(II), and the brighter signal can also be maintained for a long duration.
Conclusion
In summary, our findings demonstrated that MNP-Mn(II) had potential applications as MR stem cell tracers in vivo, owing to their excellent properties. We believe that these novel nanoparticles will be useful in studies of engrafted stem cells. In future studies, we will aim to further improve the nanostructures of the novel nanoparticles to achieve stem cell-based multimodal imaging and treatment integration, by incorporating other functional groups, such as 64 Cu 2+ , Fe 3+ , and sorafenib, into the nanoparticles. 
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Supplementary materials synthesis of water-dispersible melanin nanoparticles (MNPs)
Water-dispersible MNPs were synthesized according to a previously described procedure. 1 Briefly, 20 mg melanin (Sigma-Aldrich, St Louis, MO, USA) was dissolved in 4 mL of 0.1 M NaOH (Sigma-Aldrich) using an ultrasonic bath. HCl (37 wt%; Sigma-Aldrich) was dripped gradually to adjust the pH to 7.0-8.0, and an ultrasonic processor was used to decentralize MNPs. The obtained MNPs aqueous solution was transferred to an ultrafiltration centrifuge tube (Millipore Amicon Ultra, 30 kDa, EMD Millipore, Billerica, MA, USA) and then purified by centrifugation (4,000-5,000×g, 30 min) and washed with deionized water several times until the filtered water became clear. About 1 mL of MNP aqueous solution was left in the tube and then lyophilized for 24 h using a vacuum freeze dryer. Ultimately, ~14 mg of black solid water-dispersible MNPs was obtained.
Surface modification of MNPs
The surface of MNPs was further modified by polyethylene glycol (PEG, NH 2 -PEG5000-NH 2 , 5 kDa; Laysan Bio, Arab, AL, USA). The previously lyophilized MNPs were redissolved in alkaline solution, and the pH was adjusted to 9.5 by adding 0.1 M NaOH aqueous solution dropwise. Approximately 70 mg PEG was dissolved in ~8 mL ultrapure water in an ultrasonic bath, and the pH was also adjusted to 9.5 by adding 0.1 M NaOH aqueous solution dropwise. Under the protection of nitrogen, the PEG and MNP aqueous solutions were mixed together and stirred for 24 h at room temperature using a magnetic stirrer. The solution was then transferred to an ultrafiltration centrifuge tube and washed five times with deionized water by centrifugation (4,000-5,000×g, 15 min) to remove the free PEG. The pH of the final PEG-MNP aqueous solution was nearly 7.0.
synthesis of Mn
2+ -Peg-MNPs
In total, 4 mL of 2.5 mg/mL MNP aqueous solution was mixed with 100 µL of 100 mg/mL MnCl 2 aqueous solution and then stirred gently at 40°C for 2 h. To ensure that the MNPs were fully chelated with Mn 2+ ions, moderately excessive Mn 2+ ions were required. The molar ratio of MNPs and Mn 2+ ions in the resulting chelate was ~1:200. The obtained chelation products were then purified using a PD-10 column (GE Healthcare, Chicago, IL, USA) to removed free Mn 2+ and Cl − .
characterization of Mn
2+ -Peg-MNPs
The morphology of Mn 2+ -PEG-MNPs was observed using a transmission electron microscope (TEM; JEM-1011; JEOL, Tokyo, Japan). The hydrodynamic diameters were measured by dynamic light scattering (DLS; Zetasizer Nano ZS90; Malvern Instruments, UK). TEM images ( Figure S1B and C) and sizes distribution of DLS ( Figure S1D ) showed monodispersed spherical nanoparticles of ~5 nm (approximate range = 3-7 nm).
The Mn 2+ ion concentration in 10 mL of 0.02 mg/mL Mn 2+ -PEG-MNP aqueous solution was measured by inductively coupled plasma mass spectrometry (ICP-MS). The ICP-MS results revealed that the Mn 2+ ion concentration was about 1.74 mg/L, and the quantity of Mn 2+ ions chelated to a single MNP was about 69.5.
The stability of Mn 2+ ion-chelated MNPs was also analyzed in phosphate-buffered saline (PBS; pH = 7.4). As shown in Figure S1E, 
Fontana-Masson staining
Fontana-Masson staining (Solarbio, G2032) was performed to identify the MNP-Mn 2+ labeling rate of bone marrowderived stem cells (BMSCs). After labeling with MNP-Mn 2+ , the BMSCs were fixed with paraformaldehyde for 15 min at room temperature, washed three times with PBS, and then incubated in ammoniacal silver solution for 35 min at 56°C in a darkroom. Next, samples were rinsed five times with deionized water, soaked in 5% sodium thiosulfate solution for 5 min at room temperature, and then rinsed again with running pure water for 3 min. Finally, samples were counterstained with neutral red staining solution for 5 min at room temperature in a darkroom. The labeled BMSCs were observed using a phase-contrast microscope (E100; Nikon, Tokyo, Japan).
Black particles representing Mn 2+ -PEG-MNPs were observed in the cytoplasm of labeled BMSCs, while no black particles were observed in the cytoplasm of unlabeled BMSCs. Additionally, the Mn 2+ -PEG-MNP labeling rate of the BMSCs was nearly 100% ( Figure S2 ).
